Affordable Access

deepdyve-link
Publisher Website

Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.

Authors
  • Takenaka, Tomoyoshi
  • Takenoyama, Mitsuhiro
  • Yamaguchi, Masafumi
  • Toyozawa, Ryo
  • Inamasu, Eiko
  • Kojo, Miyako
  • Toyokawa, Gouji
  • Yoshida, Tsukihisa
  • Shiraishi, Yoshimasa
  • Morodomi, Yosuke
  • Hirai, Fumihiko
  • Taguchi, Kenichi
  • Shimokawa, Mototsugu
  • Seto, Takashi
  • Ichinose, Yukito
Type
Published Article
Journal
European Journal of Cardio-Thoracic Surgery
Publisher
Oxford University Press
Publication Date
Mar 01, 2015
Volume
47
Issue
3
Pages
550–555
Identifiers
DOI: 10.1093/ejcts/ezu227
PMID: 24894095
Source
Medline
Keywords
License
Unknown

Abstract

It is essential for recurrent NSCLC patients to be examined for the EGFR mutation status. Patients with a positive EGFR mutation status receive significant benefits from EGFR-TKI therapy.

Report this publication

Statistics

Seen <100 times